Cost Effectiveness of Quadrivalent Versus Trivalent Inactivated Influenza Vaccines for the Portuguese Elderly Population
Background: quadrivalent inactivated vaccine (QIV) has replaced trivalent inactivated vaccine (TIV). In Portugal, TIV is free of charge for risk groups, including older adults (≥65 years old). In its turn, QIV—which provides broader protection as it includes an additional lineage B strain—was introd...
Main Authors: | Diana Tavares, Helena Mouriño, Cristina Antón Rodríguez, Carlos Martín Saborido |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/8/1285 |
Similar Items
-
Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy
by: Francesco Saverio Mennini, et al.
Published: (2018-08-01) -
Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico
by: Guillermo M. Ruiz-Palacios, et al.
Published: (2020-04-01) -
Costs per DALYs Averted of Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccine in Elderly Population in Thailand
by: Jadesada Lertsirimunkong, et al.
Published: (2021-03-01) -
Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach
by: Anita J. Brogan, et al.
Published: (2017-03-01) -
The averted costs due to influenza vaccination with trivalent and quadrivalent vaccines
by: S. M. Kharit, et al.
Published: (2017-06-01)